OpenSAFELY Vaccine Coverage Report

AstraZeneca / Priority Group 6

Data from combined, up to 2021-03-20.

Vaccinated at 2021-03-20 (%) Vaccinated at 2021-03-20 (n) Population Vaccinated at 2021-03-13 (%) Vaccinated in past week (%)
Overall - 42.5% 1,771,714 4,168,045 36.6% 5.9%
Sex Female 41.7% 811,916 1,948,310 36.0% 5.7%
Male 43.2% 959,798 2,219,735 37.1% 6.1%
Ethnicity White - British 45.8% 1,016,827 2,220,869 39.4% 6.4%
White - Irish 41.4% 8,435 20,356 36.2% 5.2%
White - Any other White background 32.5% 68,684 211,624 27.5% 4.9%
Mixed - White and Black Caribbean 28.7% 3,983 13,895 24.2% 4.4%
Mixed - White and Black African 31.1% 3,269 10,514 26.2% 4.9%
Mixed - White and Asian 38.5% 3,395 8,827 32.6% 5.9%
Mixed - Any other mixed background 33.1% 5,670 17,143 28.0% 5.1%
Asian or Asian British - Indian 42.7% 46,144 108,136 37.5% 5.2%
Asian or Asian British - Pakistani 34.3% 34,489 100,639 29.0% 5.3%
Asian or Asian British - Bangladeshi 41.6% 13,531 32,557 33.9% 7.7%
Asian or Asian British - Any other Asian background 38.6% 24,080 62,447 33.5% 5.0%
Black or Black British - Caribbean 27.7% 9,492 34,244 24.0% 3.7%
Black or Black British - African 28.3% 17,311 61,075 24.0% 4.4%
Black or Black British - Any other Black background 27.0% 4,949 18,298 23.2% 3.9%
Other ethnic groups - Chinese 38.8% 5,572 14,343 31.9% 6.9%
Other ethnic groups - Any other ethnic group 32.7% 12,313 37,639 27.9% 4.9%
Patients with any other ethnicity code 41.9% 224,525 536,354 36.5% 5.4%
Ethnicity not given - patient refused NaN 0 0 NaN NaN
Ethnicity not stated 40.8% 11,347 27,804 34.1% 6.7%
Ethnicity not recorded 40.8% 257,593 631,162 35.2% 5.6%
Ethnicity (broad categories) White 44.6% 1,093,960 2,452,863 38.3% 6.3%
Mixed 32.4% 16,331 50,407 27.4% 5.0%
South Asian 38.9% 118,272 303,793 33.5% 5.4%
Black 27.9% 31,759 113,631 23.8% 4.1%
Other 34.4% 17,899 51,989 29.0% 5.4%
Unknown 41.3% 493,479 1,195,334 35.8% 5.5%
Index of Multiple Deprivation 1 (most deprived) 38.8% 373,751 964,019 32.8% 6.0%
2 41.2% 364,154 882,840 35.2% 6.0%
3 43.4% 356,202 820,862 37.7% 5.7%
4 44.8% 338,338 755,496 39.0% 5.8%
5 (least deprived) 46.0% 324,240 705,593 39.8% 6.2%
Unknown 38.3% 15,015 39,200 34.6% 3.7%
Clinical Risk Groups Patients in Any Clinical Risk Group 42.5% 1,771,721 4,168,045 36.6% 5.9%
Patients with Immunosuppression 43.2% 101,850 235,956 37.9% 5.3%
Patients with CKD 45.0% 96,068 213,542 40.5% 4.5%
Patients who have Chronic Respiratory Disease 41.8% 156,520 374,591 35.8% 5.9%
Patients with Diabetes 44.4% 446,593 1,005,697 40.2% 4.2%
Patients with Chronic Liver disease 40.3% 198,415 492,142 33.4% 6.9%
Patients with CNS Disease (including Stroke/TIA) 43.0% 356,391 829,549 36.7% 6.3%
Patients with Chronic heart disease 44.4% 486,752 1,095,934 38.1% 6.3%
Patients with Asplenia or Dysfunction of the Spleen 42.9% 58,849 137,025 37.5% 5.5%
Patients with Wider Learning Disability 47.2% 76,027 161,161 42.5% 4.7%
Patients with Severe Mental Health 37.2% 121,856 327,425 31.2% 6.0%
Other Groups Patients with Morbid Obesity 46.8% 103,950 222,194 41.6% 5.2%
Patients who are pregnant 11.7% 3,696 31,633 9.1% 2.5%